RecruitingNot ApplicableNCT07556185

MedlyPeds Feasibility Study

MedlyPeds Feasibility Study: A Mobile, Smartdevice Based Telemonitoring for Pediatric Heart Disease, a Prospective Cohort Study

Sponsor

The Hospital for Sick Children

Enrollment

30 participants

Start Date

Jul 1, 2026

Study Type

INTERVENTIONAL

Conditions

Pediatric Heart Failure Congenital Heart Disease (CHD)Acquired Heart Disease Pulmonary Hypertension Post-cardiac surgery

Summary

SickKids and UHN have developed MedlyPeds which is a smart phone application designed to remotely monitor patients with heart disease. This is a feasibility study which will enroll up to 30 patients with different types of heart disease to see which patient types may benefit the most from MedlyPeds if it were to be used for clinical monitoring. The study is gathering feedback about the app from patients, parents and clinicians to confirm how it needs to be modified to better serve the purpose in a future trial.

Eligibility

Min Age: 8 YearsMax Age: 18 Years

Inclusion Criteria9

Consent provided.
Aged 8-18 years of age.
Ability to comply with using Medly (ex. able to stand on the weight scale, able to answer symptom questions, etc.)
Followed at the Hospital for Sick Children Cardiology Clinic for any of the following reasons:
Heart failure of any etiology
Congenital heart disease
Acquired heart disease (eg. Kawasaki disease, rheumatic heart disease, connective tissue disorders etc)
Pulmonary hypertension
Post-cardiac surgery including heart transplant and ventricular assist devices

Exclusion Criteria2

Unable to read or write in English.
Participating in another clinical trial that may confound the results.* *Participant may be re-screened for eligibility at a later date.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEMedlyPeds App

The mobile phone-based telemonitoring system (MedlyPeds) will enable cardiac patients to monitor their weight, blood pressure, and heart rate, using wireless home medical devices. In addition, they will answer questions about their symptoms and wellness using their mobile phone. The device measurements will be automatically and wirelessly transmitted to the mobile phone and then to a data server. Automated and individualized self-care messages, developed with the assistance of healthcare providers, will subsequently be sent to the patient based on the readings and reported symptoms.